ENTHEON BIOMEDICAL CORP.ENTHEON BIOMEDICAL CORP.ENTHEON BIOMEDICAL CORP.

ENTHEON BIOMEDICAL CORP.

No trades
See on Supercharts

ENTBF fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Entheon Biomedical Corp. is a biotechnology company, which engages in developing and commercializing dimethyltryptamine based psychedelic therapeutic products. Its therapies aim to treat addiction and substance use disorders. The company was founded on April 6, 2010 and is headquartered in Vancouver, Canada.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

ENTBF does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company